News
Cancer spreads fast and hits hard, especially when it reaches other organs. Once that happens, treatments become less ...
AI-derived predictive biomarker identifies two thirds of patients with high-risk prostate cancer who may benefit from ...
A control PNA turned antimicrobial agent may help eliminate F. nucleatum, a gut microbe tied to cancer progression and ...
Corbin Burnes consiguió su primera victoria para Arizona y el bateador emergente dominicano Geraldo Perdomo pegó un sencillo ...
Cells have a mailing system of sorts. They can release tiny molecular balls, called extracellular vesicles (EVs), that ...
Update on CAPItello-280 Phase III trial of Truqap in metastatic castration-resistant prostate cancer
AstraZeneca is discontinuing the CAPItello-280 Phase III trial evaluating the efficacy and safety of Truqap (capivasertib) in combination with docetaxel and androgen-deprivation therapy (ADT) compared ...
El boricua Francisco Lindor y el dominicano Starling Marte conectaron sendos vuelacercas de dos carreras en las primeras entradas, y los Mets de Nueva York brillaron a la ...
The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...
Pilatus Biosciences Publishes Preclinical Data in Cancer Discovery on PLT012 First-in-Class CD36-Targeting Antibody for Liver ...
It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.
People live on average a little over two years after an mCRPC diagnosis. Find statistics here and learn how treatment ...
According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results